AbbVie to buy rival pharmaceutical company Allergan in “transformative” deal valued at $63 billion

By Associated Press - Tuesday, June 25, 2019

NEW YORK (AP) - AbbVie to buy rival pharmaceutical company Allergan in “transformative” deal valued at $63 billion.

Silver charm found in Germany is oldest evidence of Christianity north of the Alps